Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 3
Author(s): Rosa Tundis*
Affiliation:
- Associate Professor, Department of Pharmacy, Health and Nutritional Sciences of University of Calabria, Via P. Bucci, Edificio Polifunzionale-87036 Arcavacata Rende (CS),Italy
Export Options
About this article
Cite this article as:
Tundis Rosa*, Meet Our Editorial Board Member, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2016; 15 (3) . https://dx.doi.org/10.2174/187152301503170421205629
DOI https://dx.doi.org/10.2174/187152301503170421205629 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Developments in Cholinesterases Inhibitors for Alzheimers Disease Treatment
Current Medicinal Chemistry Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation Associated with Parkinsons Disease
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Inhaled Anesthetic Modulation of Amyloid β 1-40 Assembly and Growth
Current Alzheimer Research The Role of the Endoplasmic Reticulum in the Accumulation of β-Amyloid Peptide in Alzheimers Disease
Current Molecular Medicine Nerve Growth Factor: A Focus on Neuroscience and Therapy
Current Neuropharmacology Red Cell Glycolytic Enzyme Disorders Caused by Mutations: An Update
Cardiovascular & Hematological Disorders-Drug Targets New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders
Central Nervous System Agents in Medicinal Chemistry Wnt/β-Catenin Signaling in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Structural variations and molten globule state in Arisaema helliborifolium lectin under various treatments as monitored by spectroscopy
Protein & Peptide Letters Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease
Current Alzheimer Research The Use of Chronobiotics in the Resynchronization of the Sleep/Wake Cycle. Therapeutical Application in the Early Phases of Alzheimer's Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Motor Neuron Disease and Acquired Axonal Neuropathy Association in HIV Infection: Case Report and Update
Current HIV Research Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies
Current Drug Delivery Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration
Current Neurovascular Research Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes
CNS & Neurological Disorders - Drug Targets Cubosomes: Innovative Nanostructures for Drug Delivery
Current Drug Delivery Patent Selections
Recent Patents on Drug Delivery & Formulation Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
Current Neuropharmacology